Announcements

    Drinks

      Scope proposes updated Financial Institutions methodology and calls for comments

      4/8/2025 Research EN

      Scope proposes updated Financial Institutions methodology and calls for comments

      Scope Ratings requests comments on its Financial Institutions Rating Methodology by 4 September 2025. The proposed changes to the methodology are not expected to have an impact on outstanding ratings assigned by Scope.

      Scope proposes an update to its Sub-Sovereigns Rating Methodology and invites comments

      30/7/2025 Research EN

      Scope proposes an update to its Sub-Sovereigns Rating Methodology and invites comments

      Scope Ratings calls for comments on its Sub-Sovereigns Rating Methodology by 1 September 2025. The proposed update refines Scope’s analytical approach. No rating changes are expected as a result of this update.

      Scope publishes final Chemicals Rating Methodology

      30/6/2025 Research EN

      Scope publishes final Chemicals Rating Methodology

      The methodology is now final following a call-for-comments period and will apply to all issuer and debt ratings of chemicals companies. The methodology might have a positive impact of one notch for one rated entity.

      Scope publishes retail and wholesale corporate rating methodology after a call for comments

      25/6/2025 Research EN

      Scope publishes retail and wholesale corporate rating methodology after a call for comments

      The methodology is now final and applies to all issuer and debt ratings of European retail and wholesale companies. The update refines Scope’s analytical approach and may have some negative impact on the current ratings of two issuers.

      Scope publishes final rating methodology on Pharmaceutical Companies

      4/6/2025 Research EN

      Scope publishes final rating methodology on Pharmaceutical Companies

      The methodology is now final following a call-for-comments period and will apply to all issuer and debt ratings of corporates in the sector. The application of the updated methodology will not trigger any rating changes.

      Scope publishes final rating methodology for European Real Estate Rating Methodology

      2/6/2025 Research EN

      Scope publishes final rating methodology for European Real Estate Rating Methodology

      The methodology is now final following a call-for-comments period and will apply to all issuer and debt ratings of European real estate corporates. No impact is expected on outstanding issuer and debt ratings.

      Scope updates its Supranational Rating Methodology

      23/5/2025 Research EN

      Scope updates its Supranational Rating Methodology

      Scope Ratings has published an update to its Supranational Rating Methodology, with non-material changes. No outstanding ratings are impacted.

      Scope proposes an update to its Retail and Wholesale Rating Methodology and invites comments

      25/4/2025 Research EN

      Scope proposes an update to its Retail and Wholesale Rating Methodology and invites comments

      Scope Ratings calls for comments on its Retail and Wholesale Rating Methodology by 26 May 2025. The update strengthens, refines and further clarifies Scope’s analytical approach. The methodology might have a limited negative impact on two issuers ratings.

      Scope proposes an update to its Chemicals Rating Methodology and invites comments

      14/4/2025 Research EN

      Scope proposes an update to its Chemicals Rating Methodology and invites comments

      Scope Ratings calls for comments on its Chemicals Rating Methodology by 14 May 2025. The update strengthens, refines and further clarifies the analytical approach. The methodology as proposed might have a positive impact of one notch for one rated entity.

      Scope proposes an update to its Pharmaceutical Companies’ Rating Methodology and invites comments

      4/4/2025 Research EN

      Scope proposes an update to its Pharmaceutical Companies’ Rating Methodology and invites comments

      Scope Ratings calls for comments on its Pharmaceutical Companies’ Rating Methodology by 4 May 2025. The update strengthens, refines and further clarifies Scope’s analytical approach. No impact is expected on out-standing issuer and debt ratings.